NCT01124175View on ClinicalTrials.gov

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Losartan

100 mg Tablets

DRUG

Cozaar®

100 mg Tablets

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01124175 - Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter